HER-2/neu oncogenic protein: issues in vaccine development.
about
Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.DNA vaccines: developing new strategies against cancer.The SSX family of cancer-testis antigens as target proteins for tumor therapy.Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsProgress in the development of a therapeutic vaccine for breast cancer.Personalized dendritic cell-based tumor immunotherapy.
P2860
HER-2/neu oncogenic protein: issues in vaccine development.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
HER-2/neu oncogenic protein: issues in vaccine development.
@ast
HER-2/neu oncogenic protein: issues in vaccine development.
@en
type
label
HER-2/neu oncogenic protein: issues in vaccine development.
@ast
HER-2/neu oncogenic protein: issues in vaccine development.
@en
prefLabel
HER-2/neu oncogenic protein: issues in vaccine development.
@ast
HER-2/neu oncogenic protein: issues in vaccine development.
@en
P1476
HER-2/neu oncogenic protein: issues in vaccine development.
@en
P2093
P577
1998-01-01T00:00:00Z